Farther Finance Advisors’s Aardvark Therapeutics AARD Stock Holding History

Farther Finance Advisors’s Portfolio AARD Stock Details AARD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$90	Sell	17 -136	-89%	-$830	﹤0.01%	5976
2026 Q2	$867	Buy	153 +125	+446%	+$584	﹤0.01%	5410
2026 Q1	$115	Buy	+28	New	+$290	﹤0.01%	5497

Other funds holding AARD

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's AARD Position: Q3 2026 in Review

Farther Finance Advisors reduced its Aardvark Therapeutics (AARD) stake by 89% in Q3 2026, selling an estimated $830 and leaving 17 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #5976.

Farther Finance Advisors first reported a position in AARD in Q1 2026 and has held it in 3 quarters since. The position peaked at $867 in Q2 2026. 2 funds tracked by Wall St. Rank hold AARD as of Q3 2026.

Farther Finance Advisors held 17 shares of Aardvark Therapeutics worth $90 as of Q3 2026.
Farther Finance Advisors sold 136 Aardvark Therapeutics shares in Q3 2026, an estimated $830.
Aardvark Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5976 holding.
Farther Finance Advisors first reported a position in Aardvark Therapeutics in Q1 2026 and has held it in 3 quarters since.
Farther Finance Advisors's Aardvark Therapeutics position peaked at $867 in Q2 2026.
2 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.